Role of the angiotensin type 2 receptor in the regulation of blood pressure and renal function

Hypertension

Volumn 35, Issue 1 II, 2000, Pages 155-163

  Carey, Robert M ^a,b   Wang, Zhi Qin ^a   Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Angiotensin II; Blood pressure; Kidney; Receptors, angiotensin II; Sodium

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; BRADYKININ; CYCLIC GMP; NITRIC OXIDE; PROSTAGLANDIN;

ARTERIAL PRESSURE; AUTOCRINE EFFECT; BLOOD PRESSURE REGULATION; BODY FLUID; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; ELECTROLYTE BALANCE; HUMAN; KIDNEY FUNCTION; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 0033956854     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.35.1.155     Document Type: Conference Paper

References (92)

1. Goodfriend TL, Elliott ME, Catt KJ. Angiotensin receptors and their antagonists. N Engl J Med. 1996;334:1649-1654.
2. Griendling KK, Lassegue B, Alexander RW. Angiotensin receptors and their therapeutic implications. Ann Rev Pharmacol Toxicol. 1996; 36:281-306.
3. Matsukawa T, Ichikawa I. Biological functions of angiotensin and its receptors. Ann Rev Physiol. 1997;59:395-412.
4. Ardaillou R. Angiotensin II receptors. J Am Soc Nephrol 1999;10: S30-S39.
5. Chiu AT, McCall DE, Price WA, Wong PC, Carini DI, Duncia JV, Wexler RR, Yoo SE, Johnson AL, Timmermans PB. Nonpeptide angiotensin II receptor antagonists, VII: cellular and biochemical pharmacology of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther. 1990;252:711-718.
6. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini D, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45: 205-251.
7. Inagami T. Molecular biology and signalling of angiotensin receptors. an overview. J Am Soc Nephrol. 1999;10:S2-S7.
8. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension. 1999;33:613-621.
9. 2 receptors are in the spotlight. J Clin Invest. 1996;97:1787.
10. 1 angiotensin II receptors in the rat kidney. Renal Physiol Biochem. 1992;15:231-239.
11. Zhuo J, Alcorn D, Harris PJ, Mendelsohn FA. Localization and properties of angiotensin II receptors in rat kidney. Kidney Int. 1993; 44(suppl 42):S40-S46.
12. Shanmugam S, Llorens-Cortes C, Clauser E, Corvol P, Gase JM. Expression of angiotensin II AT2 receptor mRNA during development of the rat kidney and adrenal gland. Am J Physiol. 1995;268: F922-F930.
13. Shanmugam S, Corvol P, Gase JM. Angiotensin II type-2 receptor mRNA expression in the developing cardiopulmonary system of the rat. Hypertension. 1996;28:91-97.
14. Kakuchi J, Ichiki T, Kiyama S, Hogan BL, Fogo A, Inagami T, Ichikawa I. Developmental expression of renal angiotensin II receptor genes in the mouse. Kidney Int. 1995;47:140-147.
15. Aguilera G, Kapur S, Feuillan P, Sunar-Akbasak B, Bethia AJ. Developmental changes in angiotensin II receptor subtypes and AT1 receptor mRNA in rat kidney. Kidney Int. 1994;46:973-979.
16. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res. 1992;11:1482-1489.
17. 2) receptor protein in rat kidney. Hypertension. 1997;30:1238-1246.
18. 2) receptor protein in rat heart. Hypertension. 1998;32:78-83.
19. Lazard D, Briend-Sutren MM, Villageois P, Mattei MG, Strosberg AD, Nahmias C. Molecular characterization and chromosome localization of a human angiotensin II AT2 receptor gene highly expressed in fetal tissues. Receptors Channels. 1994;2:271-280.
20. Ichiki T, Inagami T. Expression, genomic organization and transcription of the mouse angiotensin II type-2 receptor gene. Circ Res. 1995;76:693-700.
21. Tsuzuki S, Matoba T, Eguchi S, Inagami T. Angiotensin II type-2 receptor inhibits cell proliferation and activates tyrosine phosphatase. Hypertension. 1996;28:916-918.
22. Hayashida W, Horiuchi M, Dzau VJ. Intracellular third loop domain of angiotensin II type 2 receptor: role in the cellular signal transduction and functional expression. J Biol Chem. 1996;271: 21985-21992.
23. Horiuchi M, Hayashida W, Kambe T, Yamada T, Dzau VJ. Angiotensin type 2 receptor dephosphorylates Bcl-2 by activating mitogen activated protein kinase phosphatase-1 and induces apoptosis. J Biol Chem. 1997;272:19022-19026.
24. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93: 156-160.
25. 1α3 in the rat fetus. J Biol Chem. 1996;271:15026-15033.
26. Kang J, Posner P, Sumners C. Angiotensin II type 2 receptor stimulation of neuronal K+ currents involves an inhibitory GTP binding protein. Am J Physiol. 1994;267:C1389-C1397.
27. Huang XC, Richards EM, Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem. 1996;271:15635-15641.
28. Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C. Angiotensin II type 2 receptors mediate inhibition of a mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J. 1997;325:449-454.
29. 2-mediated activation of mitogen-activated protein kinase by angiotensin II. Proc Natl Acad Sci U S A. 1998;95:8098-8102.
30. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92:10663-10667.
31. Yamada H, Horiuchi M, Akishita M, Dzau VJ. Regulation of vascular development and differentiation by angiotensin II type 2 receptor. Hypertension. 1997;30:470. Abstract.
32. 2 receptors and cellular localization of subtype mRNAs in human renal cortex using in situ hybridization. Nephron. 1998;80: 25-34.
33. 2) in rat brain. Am J Physiol. 1991;261:R209-R216.
34. Nio Y, Matsubara H, Murasawa S, Kanasaski M, Inada M. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest. 1995;95:46-54.
35. Tanaka M, Ohnishi J, Ozawa Y, Sugimoto M, Usuki S, Naruse M, Murakami K, Miyazaki H. Characterization of angiotensin II receptor type 2 during differentiation and apoptosis of rat ovarian cultured granulosa cells. Biochem Biophys Res Commun. 1995;207:593-598.
36. Kizima K, Matsubara H, Murasawa S, Maruyama K, Ohkubo N, Mori Y, Inada M. Regulation of the angiotensin II type 2 receptor gene by the protein kinase C-calcium pathway. Hypertension. 1996;27: 529-534.
37. Li JY, Avallet O, Berthelon MC, Langlois D, Saez JM. Effects of growth factors on cell proliferation and angiotensin II type 2 receptor number and mRNA in PC12 and R3T3 cells. Mol Cell Endocrinol. 1998;139:61-69.
38. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi I, Shibazaki Y, Iwasaka T, Inada M. Angiotensin type 2 receptors are re-expressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation. 1997;96:3954-3962.
39. Janiak P, Pillon A, Prost JF, Vilaine JP. Role of the angiotensin subtype 2 receptor in neointima formation after vascular injury. Hypertension. 1992;20:737-745.
40. 2 receptors subtypes in hypertrophied rat hearts. Am J Physiol. 1994;267:H844-H852.
41. Ichiki T, Kambayashi Y, Inagami T. Multiple growth factors modulate mRNA expression of angiotensin II type-2 receptor in R3T3 cells. Circ Res. 1995177:1070-1076.
42. Kambayashi Y, Nagata K, Ichiki T, Inagami T. Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular smooth muscle cells. Eur J Biochem. 1996;239: 558-565.
43. Horiuchi M, Yamada T, Hagashida W, Dzau VJ. Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J Biol Chem. 1997;272:11952-11958.
44. 2 receptor protein in rats with angiotensin-dependent hypertension. Hypertension. 1999;33:96-101.
45. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol. 1996;122:59-67.
46. 2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
47. 2 receptor. Kidney Int. 1998;53:92-96.
48. Kuizinga MC, Smits JFM, Arends JW, Daemen MJAP. AT2 receptor blockade reduces cardiac interstitial cell DNA synthesis and cardiac function after rat myocardial infarction. J Mol Cell Cardiol. 1998;30: 425-434.
49. Rang J, Sumners C, Posner P. Angiotensin II type 2 receptor-modulated changes in potassium currents in cultured neurons. Am J Physiol. 1993;265:C607-C616.
50. 2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. J Biol Chem. 1995;270:1670-1674.
51. 2) receptor promotes axonal regeneration in the optic nerve of adult rats. J Exp Med. 1998;188:661-670.
52. 2 receptor. Brain Res Mol Brain Res. 1998;53:187-195.
53. 2 receptor down-regulates neurofilament M in PC12W cells. Neurosci Lett. 1997;227:29-32.
54. Jin X-H, Wang Z-Q, Siragy HM, Guerrant RL, Carey RM. Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol. 1998;275:R515-R523.
55. Jin X-H, Siragy HM, Guerrant RL, Carey RM. Compartmentalization of extracellular guanosine cyclic 3′, 5′ monophosphate determines absorptive or secretory responses in the rat jejunum. J Clin Invest. 1999;103:167-174.
56. Arendshorst WJ, Brannstrom K, Ruan X. Actions of angiotensin II on the renal microvasculature. J Am Soc Nephrol. 1999;10:5149-5161.
57. Navar LG, Inscho EW, Majid SA, Imig JD, Harrison-Bernard LM, Mitchell KD. Paracrine regulation of the renal microcirculation. Physiol Rev. 1996;76:425-536.
58. Zou AP, Wu F, Cowley AW Jr. Protective effect of angiotensin II-induced increase in nitric oxide in the renal medullary circulation. J Auton Pharmacol. 1998;31:271-276.
59. Alonso-Galicia M, Sun CW, Falck JR, Harder DR, Roman RJ. Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries. Am J Physiol. 1998;275:F370-F378.
60. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium-derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest. 1998;91:2012-2019.
61. 2 production in conscious rats. J Clin Invest. 1996;97:1978-1982.
62. 2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264-269.
63. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988;333:664-666.
64. 2 and nitric oxide. Hypertension. 1997;29: 757-762.
65. Siragy HM, Jaffa AA, Margolius HS, Carey RM. Renin-angiotensin system modulates renal bradykinin production. Am J Physiol. 1996; 271:R1090-R1095.
66. 2 receptor in a renal wrap hypertension model. Hypertension. 1999;33: 1237-1242.
67. 2 receptor stimulation increases aortic cyclic GMP in SHRSP by kinin-dependent mechanisms. Hypertension. 1998;31:349-355.
68. 2) angiotensin receptor. Proc Natl Acad Sci U S A. 1999;96:6506-6510.
69. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioral and cardiovascular effects of disrupting the angiotensin II type 2 receptor gene in mice. Nature. 1995;377:744-747.
70. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T. Effects on blood pressure and exploratory behavior of mice lacking the angiotensin type 2 receptor. Nature. 1995;377:748-750.
71. Jacob LS, Douglas JG. Angiotensin II type 2 receptor subtype modulates phospholipase A2-dependent signaling. Hypertension. 1996;28: 663-668.
72. 2 receptor: signalling and transport. J Am Soc Nephrol. 1999;10:S69-S74.
73. Badr KF, Jacobson HR. Arachidonic acid metabolites and the kidney. In: Brenner BM, Rector FC Jr, eds. The Kidney. Philadelphia, Pa: WB Saunders Co; 1991:584-619.
74. 2α formation. Am J Physiol. 1997;273: R1103-R1107.
75. 2-9-ketoreductase as a mediator of salt intake-related prostaglandin-renin interaction. Nature. 1997;266:65-66.
76. Siragy HM, Senbonmatsu T, Ichiki T, Inagami T, Carey RM. Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor. J Clin Invest. 1999;104: 181-188.
77. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, Abe M, Takeuchi K, Abe K, Ito S. Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of the angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1997;100:2816-2823.
78. Endo Y, Arima S, Yaoita H, Tsunoda K, Omata K, Ito S. Vasodilation mediated by angiotensin II type 2 receptor is impaired in afferent arterioles of young spontaneously hypertensive rats. J Vasc Res. 1998;35:421-427.
79. 2 knockout mice. Biochem Biophys Res Commun. 1999;258:194-198.
80. Inagami T, Eguchi S, Numaguchi K, Motley ED, Tang H, Matsumoto T, Yamakawa T. Cross-talk between angiotensin II receptors and the tyrosine kinases and phosphatases. J Am Soc Nephrol. 1999;10:S57-S61.
81. 2-subtype receptors n the blood pressure lowering effect of losartan in salt-restricted rats. J Hypertens. 1999; 16:2039-2043.
82. Tsutsumi Y, Matsubara H, Masaki H, Kurihara T, Murasawa S, Takai S, Miyazuki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahasi H, Iwasaka T. Vascular smooth muscle-targeted over expression of angiotensin II type 2 receptor causes endothelium-dependent depressor and vasodilative effects via activation of the vascular kinin system. J Clin Invest. 1999;104:855-864.
83. Lo M, Liu KL, Lantelme P, Sassard J. Subtype 2 of angiotensin receptors controls pressure natriuresis in rats. J Clin Invest. 1995;95:1394-1397.
84. Liu KL, Lo M, Grouzmann E, Mutter M, Sassard J. The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys. Br J Pharmacol. 1999;126:826-832.
85. 2 receptor. Kidney Int. 1999. In press.
86. Knox FG, Granger JP. Control of sodium excretion: an integrative approach. In: Windhager EE, ed. Handbook of Physiology: Renal Physiology. Oxford, England: American Physiological Society, Oxford University Press; 1992:927-967.
87. 2 receptors. Endocrinology. 1997;38:2195-2198.
88. Liu YH, Yang XP, Sharov VG, Nass O, Sabbah HN, Petersen E. Carretero OA. Effects of angiotensin converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. J Clin Invest. 1997;99:1926-1935.
89. 1 receptor-mediated pressor and chronotropic effects. J Clin Invest. 1998;101:527-535.
90. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial pressure. Hypertension. 1996;27: 760-765.
91. Levy BI, Qui HY, Duriez M, deGasparo M. Role of angiotensin II receptor subtypes in the development of collateral vessels in rats with chronic limb ischemia. J Hypertens. In press.
92. Gyurko R, Kimura B, Kurian P, Crews FT, Phillips MI. Angiotensin II receptor subtypes play opposite roles in regulating phosphatidylinositol hydrolysis in rat skin slices. Biochem Biophys Res Commun. 1992;186:285-292.